SILO PHARMA, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $846.5K | $579.2K |
| FY2017 | — | $1.2M | $294.6K |
| FY2018 | — | $407.4K | $336.7K |
| FY2019 | — | $-22.9K | $111.8K |
| FY2020 | — | $1.3M | $1.1M |
| FY2021 | — | $9.1M | $9.8M |
| FY2022 | — | $10.3M | $11.4M |
| FY2023 | — | $6.2M | $3.5M |